Ming Guo, M.D.

Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

About Dr. Ming Guo

I am a clinical-track faculty in Cytopathology Section. My clinical and patient care activities are mainly to make pathology diagnoses and provide pathologic consultation to the clinicians in multiple services in MD Anderson Cancer Center. In cytopathology section, I provide interpretation of the image-guided biopsy, i.e. fine needle aspiration (FNA) and needle core biopsies, which mostly direct clinical decisions for surgical interventions. My research activities include clinical research for patient care and translational research. In clinical research, I focus on cervical cancer prevention with HPV/molecular testing in Pap specimens by validation testing assays. In addition, I made contributions on molecular testing using FNA material. In translational study, I focus on lung cancer early detection using miRNA markers.

Primary Appointment

Professor, School of Health Professions, The University of Texas MD Anderson Cancer Center, School of Health Professions, Houston, TX

Professor, Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, School of Health Professions, The University of Texas MD Anderson Cancer Center, School of Health Professions, Houston, TX

Honorary Professor, Ministry of Health, Beijing Hospital, Beijing

Education & Training

Degree-Granting Education

1986	Peking Union Medical College, Beijing, CN, M.S. in Pathology
1982	Beijing Medical University, Beijing, CN, MD

Postgraduate Training

1996-1997	Fellowship in Cytopathology, Department of Pathology/Cytopathology Division The University of Mississippi Medical Center, Jackson, Mississippi
1993-1996	Residency Training in Anatomic Pathology, Memorial University of Newfoundland, St. John's
1990-1993	Postdoctoral Research Fellowship, Department of Medicine, Kingston
1987-1989	Postdoctoral Research Fellowship, Department of Cell Biology and Neuroscience University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
1983-1986	Postgraduate training in Anatomic Pathology, Fuwai Hospital Peking Union Medical College, Beijing

Licenses & Certifications

2004	Texas Medical Board
2002	The Medical Board of California, Physician and Surgeon
1999	The American Board of Pathology: Diplomat of the American Board of Pathology in Cytopathology
1996	The American Board of Pathology: Diplomat of the American Board of Pathology in Anatomic Pathology

Experience & Service

Faculty Academic Appointments

Associate Professor, School of Health Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017

Associate Professor, Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017

Assistant Professor, School of Health Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

Assistant Professor, Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

Assistant Professor, School of Health Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

Assistant Professor, Department of Pathology/Cytopathology Division, The University of Mississippi Medical Center, Jackson, MS, 1997 - 2004

Administrative Appointments/Responsibilities

Chief Resident, Memorial University of Newfoundland, St. John's, 1995 - 1996

Other Professional Positions

Cytopathology Faculty Selection Committee, University of Texas of MD Anderson Cancer Center, Houston, 2019 - Present

HPV Laboratory, Department of Pathology, Cytopathology Section, Houston, TX, 2016 - Present

Intramural Institutional Committee Activities

Member, Credentials Committee of the Medical Staff (CCMS), The University of Texas MD Anderson Cancer Center, 2023 - 2028

Extramural Institutional Committee Activities

Member, The Institutional Research Grants (IRG) Program, The University of Texas MD Anderson Cancer Center, 2019 - 2021

Member, The Institutional Research Grants (IRG) Program, The University of Texas MD Anderson Cancer Center, 2015 - 2018

Member, The Institutional Research Grants (IRG) Program, The University of Texas MD Anderson Cancer Center, 2011 - 2014

Member, Scientific Publication Advisory Group, The University of Texas MD Anderson Cancer Center, 2006 - Present

Member, Medical Record Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2009

Editorial Activities

Reviewer, Cytopathology, 2020 - Present

Reviewer, Expert Review of Vaccines, 2019 - Present

Reviewer, British Medical Journal, 2016 - Present

Reviewer, Journal of Reproductive Medicine, 2015 - Present

Reviewer, European Journal of Obstetrics and Gynecology, 2014 - Present

Reviewer, Archives of Pathology and Laboratory Medicine, 2014 - Present

Reviewer, Journal of the American Society of Cytopathology, 2013 - Present

Reviewer, Molecular Diagnostics, 2013 - Present

Reviewer, Mod Path, 2012 - Present

Reviewer, Journal of Thoracic Oncology, 2012 - Present

Reviewer, BMC Cancer, 2010 - Present

Reviewer, Cancer Research and Treatment, 2009 - Present

Reviewer, Human Pathology, 2007 - Present

Reviewer, Journal of Cellular and Molecular Medicine, 2006 - Present

Reviewer, Quantitative Cytopathology, 2006 - Present

Reviewer, Gynecological Oncology, 2005 - Present

Reviewer, Histology and Histopathology, 2005 - Present

Reviewer, Cancer Cytopathology, 2005 - Present

Honors & Awards

2020	President's Recognition of Faculty Excellence, Prevention Outreach, MD Anderson Cancer Center
2020	Outstanding post-doctoral fellow in cancer prevention, DCPPS 2020, MD Anderson Cancer Center
2018	2018 the Conquer Cancer Foundation and ASCO Young Investigator Award,collaborated with Dr. Jad Chahoud, Medical Oncology/Hematology
2016	The Finalists in the Clinical Research Category for Trainee Research Day, Co-mentor of Bing Leng, MD Anderson Cancer Center
2016	The second place Resident Research Award, mentor for Suzanne Crumley, The Papanicolaou Society of Cytopathology, USCAP 2016
2015	Clinic Fellow Research Award, Department of Pathology, MD Anderson Cancer Center
2015	Co-author, Cytotechnologist Scientific Presentation Award, American Society of Cytopathology
2015	Sponsor author, 'EGFR and KRAS mutations in lung carcinoma',Top-cited Article in 2014, Cancer Cytopathology
2015	Clinic Fellow Research Award, Mentor for Dr. Suzanne Crumley, Department of Pathology, MD Anderson Cancer Center
2012	Honorable Mention of a specific presentation (sponsor author), American Society of Cytopathology
2009 - 2010	American Society of Cytopathology Cervical Cytology and HPV Partnership Investigator Award, American Society of Cytopathology
2005 - 2006	Jay and Lori Eisenberg Clinical Fellowship Award, The University of Texas MD Anderson Cancer Center
1992 - 1993	Cecil Patient Reid Fellowship, Faculty of Medicine, Queen's University Ontario, Canada
1986	Excellence in Research, Chinese Academy of Medical Sciences/Peking Union Medical College

Professional Memberships

College of American Pathologists

2018 - Present

American Medical Association

2018 - 2022

International Academy of Cytology

2015 - Present

Chinese-American Pathology Association

2010 - Present

Texas Medical Association

2007 - Present

Harris County Medical Society

2007 - Present

American Society of Cytopathology

1996 - Present

American Society of Clinical Pathologists

1996 - Present

Selected Presentations & Talks

Local Presentations

2024. HPV testing in cytopathology, our experience and practice in MD Anderson Cancer Center. Conference. Houston, Texas, US.
2020. HPV testing in head and neck FNA specimen from patients with oropharyngeal carcinoma, Diagnostic Patholoy Course. Conference. HPV testing in head and neck FNA specimen from patients with oropharyngeal carcinoma, Diagnostic Patholoy Course. Houston, TX, US.
2015. HPV/DNA Testing and Clinical Application. Conference. HPV/DNA Testing and Clinical Application. Houston, TX, US.
2010. HPV DNA Testing in Cervical Cancer Prevention and Beyond. Conference. HPV DNA Testing in Cervical Cancer Prevention and Beyond. Houston, TX, US.
2009. The Role of HPV DNA Testing in Cervical Cancer Prevention and Beyond. Conference. The Role of HPV DNA Testing in Cervical Cancer Prevention and Beyond. Houston, TX, US.
2006. Real-time Quantitative PCR for Human Papillomavirus Genotyping and Determination of Viral Load and Integration in Cervical Cancer and Precancer Lesions. Conference. Real-time Quantitative PCR for Human Papillomavirus Genotyping and Determination of Viral Load and Integration in Cervical Cancer and Precancer Lesions. Houston, TX, US.
2005. The Inform HPV DNA Testing and HPV Genotyping by Real-time PCR. Conference. The Inform HPV DNA Testing and HPV Genotyping by Real-time PCR. Houston, TX, US.

Regional Presentations

2004. HPV Testing, Current Clinical Application and Future Potentials. Conference. HPV Testing, Current Clinical Application and Future Potentials. Jackson, MS, US.
1997. Review of 308 Computerized Tomography Guided Fine Needle Aspiration Lung Biopsies. Conference. Review of 308 Computerized Tomography Guided Fine Needle Aspiration Lung Biopsies, US.

National Presentations

2025. HPV Correlation Study between Cobas HPV and RNAScope in-situ Hybridization Testing in Head and Neck FNA Biopsy Specimens. Conference. USCAP. Boston, MA, US.
2022. The Efficacy of Cobas HPV Testing to Predict CIN 2+ Lesion in CAncer Prevention Center and Gynecology Oncology Clinic, , A Single Institution Experience. Conference. The 21st International Congress of Cytology presented jointly with ASC's 70th Annual Scientific Meeting. Baltimore, MD, US.
2022. A prospective study of the prevalence of anal dysplasia among women with high-grade cervical, vaginal, an vulvar dysplasia or cancer. Conference. SGO 2022 Annual Meeting on Women's Cancer (platform oral presentation). Phoenix, AZ, US.
2021. Predictive value of Cobas HPV testing for oropharyngeal squamous cell carcinoma in FNA specimens from Patients with head and neck squamous cell carcinoma. Conference. 68th Annual Scientific Meeting. Las Vegas, NV, US.
2021. Phase I/II trial of encorafenib, cetuximab and nivoumab in microsatellite stab;e. FRAFV600E metastatic colorectal. Conference. 2021 ASCO Annual Meeting, US.
2020. Predictive value of the Paris System for reporting urinary cytology fro high-grade urothelial carcinoma in renal pelvic washing specimens. Conference. 68th Annual Scientific Meeting, US.
2020. Cumulative risk HSIL during a long-term follow-up woman with Pap-/HPV+ baseline testing results in a cervical cancer screening population and a cancer surveillance population. Conference. 109th United States and Canadian Academy of Pathology Annual Meeting. Los Angeles, CA, US.
2019. P16INK4a expression and survival outcomes in patients with penile squamous cell carcinoma. Conference. ASCO. Chicago, IL, US.
2019. Comparison of Cobas 4800 HPV and Cervista HPV HR Assays for Detecting High-risk HPV in SurePath Pap Specimens. Conference. 108th United States and Canadian Academy of Pathology Annual Meeting. National Harbor, MD, US.
2019. The Efficacy of HPV16/18 Genotyping in Women with Pap-/HPV+ Co-testing Results in a Cervical Cancer Screening Population and a Cancer Surveillance Population. Conference. 107th United States and Canadian Academy of Pathology Annual Meeting. National Harbor, MD, US.
2017. Diagnostic Accuracy and Efficacy of Renal Pelvic Washing: Clinical and Pathologic Correlation. Conference. Poster Presentation: 65th ASC's Annual Scientific Meeting. Phoenix, AZ, US.
2017. Potential factors that could lead to false positive FNA diagnosis. Conference. Poster Presentation: 65th ASC's Annual Scientific Meeting. Phoenix, AZ, US.
2016. Correlation of FISH and NGS Results of Lung Adenocarcinoma Cytology Samples Stratified by Molecular Subtypes. Conference. Poster Presentation: AMP Annual Meeting. Charlotte, NC, US.
2016. Flourescence in-situ Hybridization Testing in Cytology Specimens of Patients with Lung Carcinoma. Conference. Poster Presentation: 64th ASC's Annual Scientific Meeting. New Orleans, LA, US.
2016. Challenge of Fine Needle Aspiration Diagnosis of Angiomyolipoma: A Study of 33 Cases. Conference. 105th USCAP Annual Meeting 2016. Seattle, WA, US.
2016. False Negative HPV Tests in Women with High Grade Squamous Epithelial Lesion or Carcinoma Pap Tests: Clinical-Pathological Correlation. Conference. 105th USCAP Annual Meeting 2016. Seattle, WA, US.
2016. Accuracy of the EasyChip HPV Blot Genotyping Assay in Detecting High-Risk HPV Genotypes in SurePath Pap Specimens. Conference. 47th SGO Annual Meetiing on Women's Cancer Poster Presentation. San Diego, CA, US.
2015. The Utility of Cervista Human Papillomavirus Assay in Necrotic Fine-needle Aspiration Specimens of Metastic Squamous Cell Carcinoma from Neck Lymph Nodes. Conference. 63rd ASC's Annual Scientific Meeting Poster Presentation. Chicago, IL, US.
2015. Efficacy of HPV Testing in Predicting CIN2+ in Women with an Unsatisfactory Pap Cytology Result. Conference. 63rd Annual Scientific Meeting ASC Poster Presentation. Chicago, IL, US.
2015. Clinical Performance of Cervista HPV HR adn HC2 Co-testing with SurePath Pap Cytology. Conference. 63rd Annual Scientific Meeting ASC Poster Presentation. Chicago, IL, US.
2015. GAP Conference 2015. Conference. GAP Conference 2015. Houton, TX, US.
2015. Predictive Value of HPV Testing for High-Grade Cervical and Vaginal Intraepithelial Lesions in Patients with Mildly Abnormal Pap Testing Results and Therapy Effects. Conference. 104th Annual Meeting. Boston, MA, US.
2014. The Efficacy of HPV16/18 Genotyping in Predicting CIN2+ in Women with HPV+/Pap Results. Conference. 62nd Annual Scientific Meeting. Dallas, TX, US.
2014. Can HPV Testing be used as a First-line Screening Test for Cervical Cancer Prevention? Three Year Cumulative Risk of CIN2+ in Women Aged 30 Years and Older Screened by Pap and HPV Co-testing. Conference. 62nd Annual Scientific Meeting, American Society of Cytopathology. Dallas, TX, US.
2014. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Conference. 103rd Annual Meeting of United States and Canadian Academy of Pathology (USCAP). San Diego, CA, US.
2013. Efficacy of Reflex HPV Testing in older, High-Risk Patients with an ASC-US Pap Results. Conference. Efficacy of Reflex HPV Testing in older, High-Risk Patients with an ASC-US Pap Results. Orlando, FL, US.
2013. Aberrant DNA Methylation of SOX1 and PAX1 in Pap Specimen: Potential Biomarkers of Cervical Intraepithelial Neoplasm Grade 3. Conference. 61st Annual Scientific Meeting. Orlando, FL, US.
2013. Validation of Cervista HPV16/18 Assay in Anal Swab Specimens. Conference. 102nd Annual Meeting. Baltimore, MD, US.
2013. Fine Needle Aspiration Is a Valid Tissue Source for EGFR and KRAS Molecular Testing in Lung Cancer: A Comparison Study with Core Needle Biopsy. Conference. 102nd Annual Meeting. Baltimore, MD, US.
2012. Endoscopic Ultrasound-Guided Fine Needle Aspiration of Metastatic Non-Hematolymphoid Neoplasms to the Pancreas. Conference. Endoscopic Ultrasound-Guided Fine Needle Aspiration of Metastatic Non-Hematolymphoid Neoplasms to the Pancreas. Las Vegas, NV, US.
2012. Validation of Cervista HPV HR and Cervista HPV 16/18 Assays in Head and Neck FNA Specimens from Patients Oropharyngeal Carcinoma. Conference. Validation of Cervista HPV HR and Cervista HPV 16/18 Assays in Head and Neck FNA Specimens from Patients Oropharyngeal Carcinoma. Las Vegas, NV, US.
2012. Validation of Cervista HPV HR DNA Testing Assay in SurePath Pap Specimens. Conference. Validation of Cervista HPV HR DNA Testing Assay in SurePath Pap Specimens. Las Vegas, NV, US.
2012. Fine Needle Aspiration of Lymphoma with Signet Ring Features. Conference. Fine Needle Aspiration of Lymphoma with Signet Ring Features. Las Vegas, NV, US.
2012. Three-Year Follow-up for Women 30 Years and Older with Negative Pap and Negative Hybrid Capture 2 HPV DNA Testing Results. Conference. Three-Year Follow-up for Women 30 Years and Older with Negative Pap and Negative Hybrid Capture 2 HPV DNA Testing Results. Las Vegas, NV, US.
2012. Cervista HPV HR and HPV16/18 Assays in Head and Neck FNA Specimens, a Valid Option of HPV Testing, Compared with HPV In Situ Hybridization/p16 Immunostaining Assays in Tissue Specimens from Patients with Oropharyngeal Carcinoma. Conference. Cervista HPV HR and HPV16/18 Assays in Head and Neck FNA Specimens, a Valid Option of HPV Testing, Compared with HPV In Situ Hybridization/p16 Immunostaining Assays in Tissue Specimens from Patients with Oropharyngeal Carcinoma. Las Vegas, NV, US.
2012. Risk of CIN2+ in Women 30 Years and Older with Negative Pap and Positive Hybrid Capture 2 HPV DNA Testing Results. Conference. Risk of CIN2+ in Women 30 Years and Older with Negative Pap and Positive Hybrid Capture 2 HPV DNA Testing Results. Las Vegas, NV, US.
2012. Validation of Cervista HPV16/18 in SurePath Pap Specimens Using a PCR-based HPV Genotyping Assay. Conference. Validation of Cervista HPV16/18 in SurePath Pap Specimens Using a PCR-based HPV Genotyping Assay. Las Vegas, NV, US.
2011. Risk Profiling Using HPV Genotyping in Women with Mildly Abnormal Pap Results (Platform Presentation). Conference. The 59th Annual Scientific Meeting of the American Society of Cytopathology. Baltimore, MD, US.
2011. Atypical epithelial cells in fine-needle aspiration biopsy of breast lesions: histologic follow-up and sources of equivocal cytologic diagnosis. Conference. The 59th Annual Scientific Meeting of the American Society of Cytopathology. Baltimore, MD, US.
2011. EGFR Mutations in Exons 18, 19 and 21 are Closely Associated with TTF-1 Positive Lung Adenocarcinoma. Conference. United States and Canadian Academy of Pathology. San Antonio, TX, US.
2011. Altered microRNA Expression in Adenocarcinoma of Lung from Smokers and Never-Smokers. Conference. United States and Canadian Academy of Pathology. San Antonio, TX, US.
2010. Predictive Value of Reflex HPV DNA Testing in Post-treatment Follow up for Women with ASC-US Pap Results. Conference. The 58th Annual Scientific Meeting of the American Society of Cytopathology. Boston, MA, US.
2010. Malignant Pleural Effusion in Pediatric and Adolescent Patients, Our Experience in a Cancer Center. Conference. The 58th Annual Scientific Meeting of the American Society of Cytopathology. Boston, MA, US.
2010. HPV Infection and Oral Cytological Changes in Patients with Oropharyngeal Squamous Carcinoma and Their Sexual Partners. Conference. The 58th Annual Scientific Meeting of the American Society of Cytopathology. Boston, MA, US.
2010. EGFR and KRAS Mutations in Cytology Specimens from Patients with Lung Carcinoma (platform presentation). Conference. The 58th Annual Scientific Meeting of the American Society of Cytopathology. Boston, MA, US.
2010. Human Papillomavirus (HPV) Transmission from Oropharyngeal Cancer Patients to Sexual Partners. Conference. The 2010 American Society of Clinical Oncology Annual Meeting. Chicago, IL, US.
2010. The Utility of Cytologic Specimens for Molecular Testing, Our Experience in a Cancer Center. Conference. 99th Annual Meeting, The United States and Canada Academy of Pathology. Washington, DC, US.
2009. Diagnostic Accuracy of Fine Needle Aspiration Biopsy for Follicular Variant of Papillary Thyroid Carcinoma. Conference. The 57th Annual Scientific Meeting of the American Society of Cytopathology. Denver, CO, US.
2009. Comparison of Two Preservation Methods of Residual Liquid-Based Pap Specimens for Future Morphology and Molecular Studies. Conference. The 57th Annual Scientific Meeting of the American Society of Cytopathology. Denver, CO, US.
2009. Co-screening Women 30 Years of Age and Older Using Hybrid Capture 2 HPV DNA Testing and Pap Cytology: 2-year Experience in a Cancer Prevention Center (Platform Presentation) The 57th Annual Scientific Meeting of the American Society of Cytopathology. Conference. The 57th Annual Scientific Meeting of the American Society of Cytopathology. Denver, CO, US.
2009. Testing Efficacies of p16, ProExC and HPV In-Situ Hybridization in Cervical Squamous Intraepithelial Lesions and Carcinoma. Conference. The United States and Canadian Academy of Pathology, 98th Annual Meeting. Boston, MA, US.
2008. FNA Biopsy of Thyroid Bed Lesions from 208 Patients with Thyroidectomy for Thyroid Carcinoma, 5 Years Experience in a Cancer Center. Conference. The 56th Annual Scientific Meeting of the American Society of Cytopathology. Orlando, FL, US.
2007. HPV DNA testing with selected HPV genotyping is more efficient than p16 immunostaining in predicting high-grade cervical intraepithelial neoplasia in women with atypical squamous cells of undetermined significance (ASC-US). Conference. The 55th Annual Scientific Meeting of the American Society of Cytopathology. Houston, TX, US.
2007. Comparison of ThinPrep and SurePath Liquid-based Cytology in Using Hybrid Capture 2 HPV DNA Testing in Women with ASC-US Pap results. Conference. The 55th Annual Scientific Meeting of the American Society of Cytopathology. Houston, TX, US.
2007. HPV DNA Co-screening with Pap Cytology in Women Age 30 and Older in a Cancer Prevention Center. Conference. The 55th Annual Scientific Meeting of the American Society of Cytopathology. Houston, TX, US.
2007. Genotyping for Eight Oncogenic Types of Human Papillomavirus Can Improve Specificity of HPV Testing in Women with Mild Abnormal Pap Results. Conference. The 60th Annual Symposium on Cancer Research, “Personalized Risk Assessment and Management”. Houston, TX, US.
2007. Distribution and Viral Load of Eight Oncogenic Types of Human Papillomavirus (HPV) and HPV 16 Integration Status in Cervical Intraepithelial Neoplasia and Carcinoma. Conference. Pathology of the 21st Century, Integrating Diagnostic and Molecular Pathology. Houston, TX, US.
2007. Comparison of in situ Hybridization with PCR for Detecting Human Papillomavirus DNA in Cervical Intraepithelial Neoplasia and Cervical Carcinoma. Conference. Pathology of the 21st Century, Integrating Diagnostic and Molecular Pathology. Houston, TX, US.
2007. Distribution and Viral Load of Eight Oncogenic Types of Human Papillomavirus (HPV) and HPV 16 Integration Status in Cervical Intraepithelial Neoplasia and Carcinoma. Conference. The United States and Canada Academy of Pathology, 96th Annual Meeting. San Diego, CA, US.
2007. Comparison of in situ Hybridization with PCR for Detecting Human Papillomavirus DNA in Cervical Intraepithelial Neoplasia and Cervical Carcinoma. Conference. The United States and Canada Academy of Pathology, 96th Annual Meeting. San Diego, CA, US.
2006. Immunohistochemical Characterization of Subtypes of Male Breast Carcinoma. Conference. The University of Texas MD Anderson Cancer Center 10th Annual Trainee Recognition Day and Research Symposium. Houston, TX, US.
2006. Immunohistochemical Characterization of Subtypes of Male Breast Carcinoma. Conference. The United States and Canada Academy of Pathology, 95th Annual Meeting. Atlanta, GA, US.
2005. Clinical Utility of Immunostains in the Differential Diagnosis of Lung Malignancies by FNA Biopsies. Conference. The 53rd Annual Scientific Meeting of the American Society of Cytopathology. San Diego, CA, US.
2005. Does HPV Genotyping Help to Predict the Presence of CIN 2/3 in Women with Mild Abnormal Pap Results?. Conference. The 53rd Annual Scientific Meeting of the American Society of Cytopathology. San Diego, CA, US.
2005. p16 Immunostain in Conjunction with Cytomorphology for Triage of Women with. Conference. The 53rd Annual Scientific Meeting of the American Society of Cytopathology. San Diego, CA, US.
2005. Real time near-infrared optical imaging guided brain tumor surgery in animal model. Conference. The Fourth Annual Meeting of the Society for Molecular Imaging, US.
2005. Early Detection of Brain and Bone Metastases using Kodak Multimodal Imaging System. Conference. The Fourth Annual Meeting of the Society for Molecular Imaging, US.
2005. Predictive Value of p16INK4a in Detection of CIN 2/3 from High-risk HPV Positive ASC-US: A Biopsy Comparison Study. Conference. The 52nd Annual Scientific Meeting of the American Society of Cytopathology. San Antonio, TX, US.
2004. Predictive Value of p16INK4a in Detection of CIN 2/3 from High-risk HPV Positive ASC-US: A Biopsy Comparison Study. Conference. The 52nd Annual Scientific Meeting of the American Society of Cytopathology. Chicago, IL, US.
2003. ASCUS Diagnoses by ThinPrep and Conventional Pap Tests: A Biopsy Follow-up Study. Conference. American Society of Cytopathology 51st Annual Scientific Meeting. Orlando, FL, US.
2003. A Better Predictive Value of p16INK4a Than High-risk HPV Testing for High-grade Cervical Intraepithelial Neoplasm. Conference. American Society of Cytopathology 51st Annual Scientific Meeting. Orlando, FL, US.

International Presentations

2019. The HPV-related oropharyngeal and uncommon cancers screening trial of men (Houston study): a perspective screening trial for HPV oropharyngeal cancer. Conference. EUROGIN 2019. Monte Carlo, MC.
2019. Comparison of Cobas HPV with Cervista HPB testing assays for detection of high-risk HPV in head and neck find-needle aspiration biopsy specimens. Conference. EurOGIN 2019. Monte Carlo, MC.
2018. Validation of a Commercial HPV Testing Assay to Detect HPV16 in Anal Cytology Specimens from a High-Risk Patient Population. Conference. EUROGIN 2018. Libson, PT.
2018. Diagnostic Efficacy of Combined Fine Needle Aspiration and Core Needle Biopsy in Patients with Lung Nodules. Conference. Abstract Presentation at the 107th USCAP Annual Meeting 2018. Vancouver, CA.
2018. Performance of Hybrid Capture 2 and Cervista HR HPV Testing Assays for Women with Atypical Squamous Cell of Undetermined Significance Pap Test Results in Cervical Cancer Screening vs. Surveillance Population. Conference. Abstract Presentation at the 107th USCAP Annual Meeting 2018. Vancouver, CA.
2017. Population-based HPV Testing Performance: Comparison HC2 and Cervista HPV Testing Assays. Conference. Poster Presentation at EUROGIN 2017. Amsterdam, NL.
2017. Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer. Conference. Abstract Presentation: ESMO 2017. Madrid, ES.
2017. Time to Re-evaluate Recommendations for Prevention of Human Papillomavirus (HPV) Infections after Stem Cell Transplantation (HSCT). Conference. Abstract Presentation: 27th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, AT.
2016. HPV testing for HPV-Associated Carcinomas, Clinical application and validation. Conference. The 2016 Chinese Cytopathology Submit and Forum (Key note speaker). Beijing, CN.
2016. Population based HPV Testing Performance: Potential False-Negative HPV Results in Cervical Cancer Surveillance Population. Conference. Poster Presentation: EUROGIN 2016. Salzburg, AT.
2015. HPV-negative PAP specimens with high grade cervical Intraepithelial lesion or cervical carcinoma. Conference. Int'l Meeting of European Society of Gynaecological Oncology (ESGO). Nice, FR.
2015. Cervista HPV 16/18 and HPV HR Assays can be used in Tissue Specimens of Oropharyngeal Squamous Carcinoma Patients to Determine High-Risk HPV Status. Conference. The 9th Asia Pacific IAP Congress. Brisbane, AU.
2014. Image-guided Deep Needle Biopsy: Clinical Application in A Cancer Center. Conference. Image-guided Deep Needle Biopsy: Clinical Application in A Cancer Center. Beijing, CN.
2014. Image-guided Deep Needle Biopsy: Clinical Application in A Cancer Center. Conference. Image-guided Deep Needle Biopsy: Clinical Application in A Cancer Center. Yangzhou, CN.
2012. Stage-associated difference in microRNA expression in lung adenocarcinoma from smokers and non-smokers. Conference. 4th WIN Symposium: Efficacy of biomarkers and personalized cancer therapeutics. Paris, FR.
2012. Stage-associated difference in microrna expression in lung adenocarcinoma from smokers and non-smokers. Conference. 4th WIN Symposium: Efficacy of biomarkers and personalized cancer therapeutics. Paris, FR.
2012. Validation of Cervista HPV16/18 in SurePath Pap Specimens Using a PCR-based HPV Genotyping Assay. Conference. Validation of Cervista HPV16/18 in SurePath Pap Specimens Using a PCR-based HPV Genotyping Assay. Vancouver, CA.
2011. Fine Needle Aspiration of Pancreas. Conference. The Annual Meeting of Shandong Group of Chinese Cytology Society. Qingdao, CN.
2011. Lung Fine Needle Aspiration Biopsy and Molecular Testing in Lung Cancer. Conference. The Annual Meeting of Shandong Group of Chinese Cytology Society. Qingdao, CN.
2010. MicroRNA profiling in lung adenocarcinoma: The 3rd Annual World Cancer Congress. Conference. The 3rd Annual World Cancer Congress. Singapore, US.
2009. HPV DNA Testing in Cervical Cancer Prevention: Practical Aspects and Clinical Validation. Conference. The 50 Annual Conference of the Japanese Society of Clinical Cytology. Tokyo, JP.
2008. Genotyping for Eight Oncogenic Types of Human Papillomavirus Can Improve Specificity of HPV Testing in Women with Mild Abnormal Pap Results. Conference. The Annual World Cancer Congress. Shanghai, CN.
2007. Genotyping for Eight Oncogenic Types of Human Papillomavirus Can Improve Specificity of HPV Testing in Women with Mild Abnormal Pap Results. Conference. The 60th Annual Symposium on Cancer Research, “Personalized Risk Assessment and Management. Monte-Carlo, MC.
2007. The Image-Guided FNA Biopsy of Lung. Conference. The 3rd International Chinese Pathology Symposium. Hebai, CN.
2007. HPV Testing in Cytopathology and Histopathology Specimens, Clinical Application and Limitation. Conference. The 3rd International Chinese Pathology Symposium. Hebai, CN.
2005. HPV Testing and p16 Immunostain in Liquid-based Pap Test: Clinical Utilization and Limitation. Conference. Symposium of the Taiwan Society of Pathology. Taipei, TW.
2005. Efficacy of p16INK4a as a triage tool for women with LSIL Pap Results. Conference. The 4th Annual Meeting of Asia-Pacific International Academy of Pathology. Beijing, CN.
2004. p16 INK4a expression and human papillomavirus types 16/18 infection in cervical intraepithelial neoplasm of adolescents. Conference. United States and Canadian Academy of Pathology Annual Meeting. Vancouver, CA.

Formal Peers

2023. A Correlation Study of Renal Pelvic Washing Cytology in Patients with Corresponding Renal Pelvic Surgical Diagnosis: Analysis on Diagnostic Discrepancy in Cytology Specimens. Invited. New Orleans, LA, US.
2016. Image-guided Lung needle biopsy, A practical approach as a cytopathologist. Invited. Beijing, CN.
2014. Image-Guided Deep Needle Biopsy: Clinical Application in a Cancer Center. Invited. Bejing, CN.
2011. Fine Needle Aspiration of Pancreas. Invited. Beijing, CN.
2010. The Clinical Utilization of HPV DNA Testing and Tumor Markers in Pap and Cervical Tissue Specimens, (Hospital grand round, CME credited). Invited. Cheyenne, WY, US.
2010. FNA of Lung and Molecular Testing in Lung Cancer. Invited. Buffalo, NY, US.
2010. The Clinical Utilization of HPV DNA Testing and Tumor Markers in Pap and Cervical Tissue Specimens (Grand round, CME credited),. Invited. Buffalo, NY, US.
2010. Cervical Cancer prevention, The Clinical Utilization of HPV DNA Testing. Invited, CN.
2010. Molecular Testing in lung cancer. Invited. Beijing, CN.
2010. Molecular Testing in lung cancer (Hospital grand round). Invited. Beijing, CN.
2010. Molecular Testing and MicroRNA in lung cancer. Invited. Beijing, CN.
2010. Practical Aspects of HPV/Tumor Marker Testing for Cervical Cancer Prevention. Invited. Cincinnati, OH, US.
2008. HPV DNA Testing: Clinical Application and Validation. Invited. Shanghai, CN.
2008. FNA Biopsy of Lung. Invited. Guangzhou, CN.
2008. HPV DNA Testing: Clinical Application and Validation. Invited. Guangzhou, CN.
2008. HPV DNA Testing: Clinical Application and Validation. Invited. Beijing, CN.
2007. The Image-Guided FNA Biopsy of Lung. Invited. Tien-jin, CN.
2007. The Image-Guided FNA Biopsy of Lung. Invited. Beijing, CN.
2007. HPV Genotyping and Potential Clinical Utilization. Invited. Taipei, TW.
2007. HPV Genotyping and Potential Clinical Utilization. Invited. Taipei, TW.
2007. HPV Testing and Clinical Application (CME credited). Invited. Spartanburg, SC, US.
2005. HPV Testing and Cervical Cancer Prevention. Invited. Beijing, CN.
2004. HPV Testing, Current Clinical Application and Future Potentials. Invited. Beijing, CN.
2004. HPV Testing, Current Clinical Application and Future Potentials. Invited. Beijing, CN.
2004. The Emerging HPV Testing and p16 in Cervical Cancer Prevention Program. Invited. Houston, TX, US.

Less

Grant & Contract Support

Date:	2024 - 2029
Title:	HPV-related Oropharyngeal Cancer Screening and Monitoring through Remote Self Sampling
Funding Source:	Baylor College of Medicine/NIH
Role:	Co-I
ID:	FP00017885_RES1

Date:	2024 - 2026
Title:	Early detection of ovarian cancer with Pap smear DNA in high-risk patient population
Funding Source:	N/A
Role:	Co-I

Date:	2023 - 2028
Title:	HPV-related Oropharyngeal Cancer Screening and Monitoring through Remote Self Sampling
Funding Source:	NIH
Role:	Co-PI

Date:	2020 - Present
Title:	Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Funding Source:	Donor Funds
Role:	Collaborator
ID:	PA18-0969

Date:	2020 - 2024
Title:	HPV-related Oropharyngeal and Uncommon Cancer Screening Trial of Men
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	Protocol 2016-0109

Date:	2019 - Present
Title:	HPV-related Oropharyngeal Cancer Screening and Monitoring through Remote Self Sampling
Funding Source:	Roche Research Award
Role:	PI

Date:	2011 - Present
Title:	Lung Cancer and Early Detection Award. Protect Your Lungs
Funding Source:	N/A
Role:	PI

Date:	2011 - Present
Title:	IRG: The Association of Altered MicroRNA Expression with the EGFR, IRAS mutations and ELM4-ALK fusion in lung adenocarcinoma, smokers vs. non-smokers
Funding Source:	N/A
Role:	PI

Date:	2011 - 2012
Title:	UT SPORE in Lung Cancer: The Altered MicroRNA Expression and their associations with the aberrant EGFR, KRAS and ELM4-ALK in Lung Adenocarcinoma
Funding Source:	N/A
Role:	PI

Date:	2010 - 2013
Title:	HPV genotyping in individual patients with multiple potentially HPV-related malignancies
Funding Source:	N/A
Role:	Collaborator
ID:	LAB10-0462

Date:	2010 - Present
Title:	Lung Cancer and Early Detection Award. Protect Your Lungs
Funding Source:	HHS/NIH/NCI
Role:	PI

Date:	2010 - Present
Title:	Epigenetic Approaches in Cancer Epidemiology (R-21)
Funding Source:	HHS/NIH/NCI
Role:	PI

Date:	2009 - 2011
Title:	Cervical Cytology and HPV Partnership Investigator Award
Funding Source:	American Society of Cytopathology
Role:	PI

Date:	2008 - 2010
Title:	Contracted with Roche, providing HPV genotyping kit (Linear Array)
Funding Source:	N/A
Role:	PI

Date:	2008 - 2009
Title:	Contracted with King Car Yuan Shan Institute (EasyChip HPV blot)
Funding Source:	N/A
Role:	PI

Date:	2007 - 2008
Title:	Contracted with Tri-Path Imaging, for providing ProExC antibody
Funding Source:	N/A
Role:	PI

Date:	2005 - 2010
Title:	HPV genotyping in oral cavity cancer
Funding Source:	N/A
Role:	Co-PI
ID:	LAB05-0287

Date:	2005 - 2006
Title:	Contracted with Ventana Medical System, for providing HPV ISH kit (INFORM HPV)
Funding Source:	N/A
Role:	PI

Date:	2004 - 2010
Title:	The University of Texas MD Anderson Cancer Center Start-Up Fund
Funding Source:	N/A
Role:	PI

Date:	2000 - 2001
Title:	American Cancer Society Institutional Research Grant
Funding Source:	American Cancer Society
Role:	PI

Date:	1998 - 1999
Title:	Biomedical Research Grant from University of Mississippi Medical Center
Funding Source:	N/A
Role:	PI

Title:	pending for Conquer cancer foundation of ASCO Identification of viral and immune biomarkers for metastasis and poor survival in penile squamous cell carcinoma
Funding Source:	American Society of Clinical Oncology (ASCO)
Role:	Collaborator

Selected Publications

Peer-Reviewed Articles

Novak, EN, Ma, A, Kundrod, KA, Chang, MM, Hansen, CJ, Montealegre, JR, Scheurer, ME, Castle, PE, Guo, M, Salcedo, MP, Schmeler, KM, Richards-Kortum, R. Extraction-free RT-RPA assay for detection of HPV16, HPV18, and HPV45 mRNA expression. Scientific reports 15(1), 2025. e-Pub 2025. PMID: 40830554.
Barra, M, Wilkinson, A, Ma, A, Goli, K, Atif, H, Osman, NM, Lorenzoni, C, Tivir, G, Lathrop, E, Castle, PE, Guo, M, Montealegre, JR, Baker, E, Salcedo, MP, Schmeler, KM, Richards-Kortum, R. One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique. Nature communications 16(1), 2025. e-Pub 2025. PMID: 40774968.
Huang, M, Ge, Y, Chen, H, Wei, C, Cogdell, D, Ivan, C, Chen, M, Zhang, W, Calin, GA, Guo, M. Stage- and smoking-associated microRNA expression in lung adenocarcinoma. Translational Lung Cancer Research 14(11):4942-4961, 2025. e-Pub 2025. PMID: 41367569.
Dahlstrom, KR, Day, AT, Alvarez, VM, Chirinos, SR, Santillana, G, Guo, M, Anderson, KS, Sturgis, EM. Circulating tumor HPV DNA, antibodies to HPV16 early proteins, and oral HPV16 DNA as biomarkers for HPV-related oropharyngeal cancer screening. Cancer biomarkers : section A of Disease markers 42(1):18758592241313323, 2025. e-Pub 2025. PMID: 40116780.
Zhao J, Shen Y, Guo M, Matin SF, Hansel DE, Guo CC. Diagnostic accuracy of upper tract urothelial carcinoma using biopsy, urinary cytology, and nephroureterectomy specimens. Am J Clin Pathol 162(5):492-499, 2024. e-Pub 2024. PMID: 38860463.
Davaro, E, Tinnirello, AA, Bevers, TB, Milbourne, A, Bassett Jr, R, Stewart, J, Guo, M. Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic. Cancer Cytopathology 132(3):152-160, 2024. e-Pub 2024. PMID: 38054363.
Morris VK, Jazaeri A, Westin SN, Pettaway C, George S, Huey RW, Grinsfelder M, Shafer A, Johnson B, Vining D, Guo M, Fellman B, Frumovitz M. Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. Oncologist 28(7):618-623, 2023. e-Pub 2023. PMID: 37104874.
Soto F, Torre-Sada LF, Mott FE, Kim ST, Nurieva R, Shannon VR, Faiz SA, Guo M, Casal RF, Altan M, Lin J, Sheshadri A. Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature 6(2):111-116, 2023. e-Pub 2023.
Batman, S, Messick, C, Milbourne, A, Guo, M, Munsell, M, Fokom Domgue, J, Salcedo, MP, Deshmukh, AA, Dahlstrom, KR, Ogburn, M, Price, A, Fleming, N, Taylor, JS, Shafer, A, Cobb, LP, Sigel, K, Sturgis, EM, Chiao, EY, Schmeler, KM. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer. Cancer Epidemiology Biomarkers and Prevention 31(12):2185-2191, 2022. e-Pub 2022. PMID: 36126275.
Chahoud, J, Millward, NZ, Pham, R, Qiao, W, Guo, M, Lu, X, Alaniz, A, Segarra, LA, Martínez-Ferrer, M, Netto, FG, Pickering, CR, Rao, P, Pettaway, CA. Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma. Cancers 14(24), 2022. e-Pub 2022. PMID: 36551510.
Guo, M, Khanna, A, Tinnirello, AA, Hwang, JP, Zhang, P, Xu, L, Li, G, Dahlstrom, KR, Sturgis, EM, Stewart, J. Detection accuracy of the Cobas HPV assay for high-risk HPV in head and neck FNA biopsy specimens. Cancer Cytopathology 130(7):523-530, 2022. e-Pub 2022. PMID: 35192231.
Yin, W, Guo, M, Tang, Z, Toruner, GA, Cheng, J, Medeiros, LJ, Tang, G. MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome. Cancers 14(10), 2022. e-Pub 2022. PMID: 35626038.
Dahlstrom, KR, Anderson, KS, Guo, M, Kwon, M, Messick, C, Pettaway, CA, Asomaning, N, Hopper, M, Price, A, Xu, L, Day, AT, Gillenwater, AM, Sturgis, EM. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men. Oral Oncology 120, 2021. e-Pub 2021. PMID: 34182223.
Yin, W, Cheng, J, Tang, Z, Toruner, GA, Hu, S, Guo, M, Robinson, M, Medeiros, LJ, Tang, G. MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non–Small-cell Lung Cancer. Clinical Lung Cancer 22(4):e512-e518, 2021. e-Pub 2021. PMID: 33288441.
Guo, M, Shlyakhova, N, Khanna, A, Tinnirello, AA, Schmeler, KM, Hwang, JP, Sturgis, EM, Stewart, J. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening. Journal of the American Society of Cytopathology 10(4):399-405, 2021. e-Pub 2021. PMID: 33967024.
Chahoud, J, Netto, FG, McCormick, B, Rao, P, Lu, X, Guo, M, Morgan, M, Chu, RA, Martínez-Ferrer, M, Eterovic, AK, Pickering, CR, Pettaway, CA. Whole-exome sequencing in penile squamous cell carcinoma uncovers novel prognostic categorization and drug targets similar to head and neck squamous cell carcinoma A C. Clinical Cancer Research 27(9):2560-2570, 2021. e-Pub 2021. PMID: 33441293.
Liu, W, Qdaisat, AZ, Ferrarotto, R, Fuller, C, Guo, M, Meyer, LA, Narayanan, S, Lopez, G, Cohen, L, Bruera, E, Hanna, EY, Yeung, SJ. Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. Cancer 127(4):528-534, 2021. e-Pub 2021. PMID: 33085092.
Liu, W, Qdaisat, AZ, Zhou, S, Fuller, C, Ferrarotto, R, Guo, M, Lai, SY, Cardoso, R, Mohamed, AS, Lopez, G, Narayanan, S, van Dijk, L, Cohen, L, Bruera, E, Yeung, SJ, Hanna, EY. Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers. Head and Neck 43(2):613-621, 2021. e-Pub 2021. PMID: 33094893.
Yin, W, Liu, W, Guo, M, Tang, Z, Toruner, GA, Robinson, M, Cheng, J, Hu, S, Medeiros, LJ, Tang, G. Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcome. Experimental and Molecular Pathology 118, 2021. e-Pub 2021. PMID: 33189723.
Huang T, Cheng X, Chahoud J, Sarhan A, Tamboli P, Rao P, Guo M, Manyam G, Zhang L, Xiang Y, Han L, Shang X, Deng P, Luo Y, Lu X, Feng S, Ferrer MM, Alan Wang Y, DePinho RA, Pettaway CA, Lu X. Effective combinatorial immunotherapy for penile squamous cell carcinoma. Nat Commun 11(1):2124, 2020. e-Pub 2020. PMID: 32358507.
Chen L, Jing H, Gong Y, Tam AL, Stewart J, Staerkel G, Guo M. Diagnostic efficacy and molecular testing by combined fine-needle aspiration and core needle biopsy in patients with a lung nodule. Cancer Cytopathol 128(3):201-206, 2020. e-Pub 2020. PMID: 31913583.
Ruiz-Cordero R, Ma J, Khanna A, Lyons G, Rinsurongkawong W, Bassett R, Guo M, Routbort MJ, Zhang J, Skoulidis F, Heymach J, Roarty EB, Tang Z, Medeiros LJ, Patel KP, Luthra R, Roy-Chowdhuri S. Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations. BMC Cancer 20(1):83, 2020. e-Pub 2020. PMID: 32005111.
Golant RT, Velez-Perez A, Krishnamurthy S, Guo M, Mousavi S, Hu MI, Varghese JM, Zafereo ME, Debnam JM. Thyroid carcinoma metastasizing to the submandibular gland: Sonographic findings 48:227-230, 2020. e-Pub 2020.
Gan Q, Joseph CT, Guo M, Zhang M, Sun X, Gong Y. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol 152(4):495-501, 2019. e-Pub 2019. PMID: 31175351.
Fokom Domgue J, Messick C, Milbourne A, Guo M, Salcedo MP, Dahlstrom KR, Chiao EY, Deshmukh AA, Sturgis EM, Schmeler KM. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol 153(2):266-270, 2019. e-Pub 2019. PMID: 30827725.
Guo M, Khanna A, Wang J, Williams MD, Kalhor N, Gong Y, Xu L, Sturgis EM, Staerkel G. Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens. Arch Pathol Lab Med 143(3):356-361, 2019. e-Pub 2019. PMID: 30221979.
Massarelli E, William W, Johnson F, Kies M, Ferrarotto R, Guo M, Feng L, Lee JJ, Tran H, Kim YU, Haymaker C, Bernatchez C, Curran M, Zecchini Barrese T, Rodriguez Canales J, Wistuba I, Li L, Wang J, van der Burg SH, Melief CJ, Glisson B. Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial. JAMA Oncol 5(1):67-73, 2019. e-Pub 2019. PMID: 30267032.
Guo M, Khanna A, Wang J, Dawlett MA, Kologinczak TL, Lyons GR, Bassett RL Jr, Sneige N, Gong Y, Bevers TB. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening. Cancer Cytopathol 125(8):644-651, 2017. e-Pub 2017. PMID: 28498639.
Zhou H, Guo M, Gong Y. Challenge of FNA diagnosis of angiomyolipoma: A study of 33 cases. Cancer Cytopathol 125(4):257-266, 2017. e-Pub 2017. PMID: 28152270.
Leng B, Guo M, Zhao J, Gong Y. Utility and pitfalls of GATA3 immunocytochemistry for diagnosis of metastatic breast carcinoma and urothelial carcinoma on cytology specimens. J Am Soc Cytopathol 6(2):73-79, 2017. e-Pub 2017. PMID: 31042637.
Amy Chen YJ, Lin CY, Feng J, Cogdell D, Zhang W, Liu J, Sneige N, Gong Y, Guo M. Accuracy of EasyChip HPV blot genotyping assay to detect high-risk HPV genotypes in SurePath Papanicolaou specimens. J Am Soc Cytopathol 5(6):351-358, 2016. e-Pub 2016. PMID: 31042547.
Wang OH, Azizian N, Guo M, Capello M, Deng D, Zang F, Fry J, Katz MH, Fleming JB, Lee JE, Wolff RA, Hanash S, Wang H, Maitra A. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer. PLoS One 11(3):e0152300, 2016. e-Pub 2016. PMID: 27023625.
Tsao AS, Papadimitrakopoulou V, Lin H, Guo M, Lee JJ, Holsinger FC, Hong WK, Sturgis EM. Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners. Infect Agent Cancer 11:21, 2016. e-Pub 2016. PMID: 27123042.
Altinmakas E, Guo M, Kundu UR, Habra MA, Ng C. Computed tomography and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis: two cases. Clin Imaging 39(6):1115-8, 2015. e-Pub 2015. PMID: 26298420.
Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology 67(2):245-54, 2015. e-Pub 2015. PMID: 25564996.
De Vivar AD, Dawlett M, Wang JP, Jack A, Gong Y, Staerkel G, Guo M. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring. Arch Pathol Lab Med 139(2):219-24, 2015. e-Pub 2015. PMID: 25611104.
Zhang YH, Liu J, Dawlett M, Guo M, Sun X, Gong Y. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Cancer Cytopathol 122(12):892-7, 2014. e-Pub 2014. PMID: 25056830.
Clevenger J, Joseph C, Dawlett M, Guo M, Gong Y. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears. Cancer Cytopathol 122(10):779-85, 2014. e-Pub 2014. PMID: 24954720.
Sneige N, Dawlett MA, Kologinczak TL, Guo M. Endosalpingiosis in peritoneal washings in women with benign gynecologic conditions: thirty-eight cases confirmed with paired box-8 immunohistochemical staining and correlation with surgical biopsy findings. Cancer Cytopathol 121(10):582-90, 2013. e-Pub 2013. PMID: 23674372.
Wang J, Katz RL, Stewart J, Landon G, Guo M, Gong Y. Fine-needle aspiration diagnosis of lymphomas with signet ring cell features: potential pitfalls and solutions. Cancer Cytopathol 121(9):525-32, 2013. e-Pub 2013. PMID: 23536424.
Zhao L, Gong Y, Wang J, Dawlett M, Huo L, Caraway NP, Guo M. Ultrasound-guided fine-needle aspiration biopsy of thyroid bed lesions from patients with thyroidectomy for thyroid carcinomas. Cancer Cytopathol 121(2):101-7, 2013. e-Pub 2013. PMID: 22605565.
Li X, Deavers MT, Guo M, Liu P, Gong Y, Albarracin CT, Middleton LP, Huo L. The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer. Mod Pathol 26(1):71-8, 2013. e-Pub 2013. PMID: 22899286.
Li Z, Austin RM, Guo M, Zhao C. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma. Arch Pathol Lab Med 136(12):1533-40, 2012. e-Pub 2012. PMID: 22900617.
Kundu UR, Guo M, Landon G, Wu Y, Sneige N, Gong Y. Fine-needle aspiration cytology of sclerosing adenosis of the breast: a retrospective review of cytologic features in conjunction with corresponding histologic features and radiologic findings. Am J Clin Pathol 138(1):96-102, 2012. e-Pub 2012. PMID: 22706864.
Kurian EM, Dawlett M, Wang J, Gong Y, Guo M. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Diagn Cytopathol 40 Suppl 1:E69-73, 2012. e-Pub 2012. PMID: 21538966.
Zhao L, Guo M, Sneige N, Gong Y. Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens. Am J Clin Pathol 137(2):304-9, 2012. e-Pub 2012. PMID: 22261458.
Guo M, Wang J, Dawlett M, Patel S, Liu P, Gong Y, Bevers T, Sneige N. Risk profiling using HPV genotyping in women with mildly abnormal Pap results. Cytojournal 8(16A), 2011. e-Pub 2011.
Wang X, Meyers C, Guo M, Zheng ZM. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer 129(6):1362-72, 2011. e-Pub 2011. PMID: 21128241.
Guo M, Warriage I, Mutyala B, Patel S, Lin E, Gong Y, Sneige N. Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance. Diagn Cytopathol 39(7):482-8, 2011. e-Pub 2011. PMID: 20607682.
Gong Y, Han EY, Guo M, Pusztai L, Sneige N. Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy. Cancer 117(4):705-13, 2011. e-Pub 2011. PMID: 20939012.
Guo M, Baruch AC, Silva EG, Jan YJ, Lin E, Sneige N, Deavers MT. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am J Clin Pathol 135(2):212-20, 2011. e-Pub 2011. PMID: 21228361.
Jiang L, Malpica A, Deavers MT, Guo M, Villa LL, Nuovo G, Merino MJ, Silva EG. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries. Int J Gynecol Pathol 29(2):146-56, 2010. e-Pub 2010. PMID: 20173500.
Siddiqi A, Spataro M, McIntire H, Akhtar I, Baliga M, Flowers R, Lin E, Guo M. Hybrid capture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance Papanicolaou results in SurePath and ThinPrep specimens. Cancer 117(5):318-25, 2009. e-Pub 2009. PMID: 19693966.
Jia R, Liu X, Tao M, Kruhlak M, Guo M, Meyers C, Baker CC, Zheng ZM. Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol 83(1):167-80, 2009. e-Pub 2009. PMID: 18945760.
Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, Gong Y, Guo M. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res 11(3):R28, 2009. e-Pub 2009. PMID: 19442295.
Guo M, Lin CY, Gong Y, Cogdell DE, Zhang W, Lin E, Sneige N. Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results. Mod Pathol 21(8):1037-43, 2008. e-Pub 2008. PMID: 18500260.
Caraway NP, Khanna A, Dawlett M, Guo M, Guo N, Lin E, Katz RL. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol 110(1):37-42, 2008. e-Pub 2008. PMID: 18433848.
Piao Y, Guo M, Gong Y. Diagnostic challenges of metastatic spindle cell melanoma on fine-needle aspiration specimens. Cancer 114(2):94-101, 2008. e-Pub 2008. PMID: 18260089.
Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol 46(1):274-80, 2008. e-Pub 2008. PMID: 17977987.
Guo M, Patel SJ, Chovanec M, Jan YJ, Tarco E, Bevers TB, Anderson K, Sneige N. A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies. Acta Cytol 51(5):749-54, 2007. e-Pub 2007. PMID: 17910345.
Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 20(2):256-66, 2007. e-Pub 2007. PMID: 17192787.
Flowers R, Baliga M, Guo M, Liu SS. Tibial adamantinoma with local recurrence and pulmonary metastasis: report of a case with histocytologic findings. Acta Cytol 50(5):567-73, 2006. e-Pub 2006. PMID: 17017449.
Ren R, Guo M, Sneige N, Moran CA, Gong Y. Fine-needle aspiration of adrenal cortical carcinoma: cytologic spectrum and diagnostic challenges. Am J Clin Pathol 126(3):389-98, 2006. e-Pub 2006. PMID: 16880150.
Gong Y, Sneige N, Guo M, Hicks ME, Moran CA. Transthoracic fine-needle aspiration vs concurrent core needle biopsy in diagnosis of intrathoracic lesions: a retrospective comparison of diagnostic accuracy. Am J Clin Pathol 125(3):438-44, 2006. e-Pub 2006. PMID: 16613349.
Guo M, Hu L, Martin L, Liu S, Baliga M, Hughson MD. Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based tests and cervical biopsies on 782 women with previously abnormal Pap smears. Acta Cytol 49(2):132-8, 2005. e-Pub 2005. PMID: 15839615.
Hu L, Guo M, He Z, Thornton J, McDaniel LS, Hughson MD. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol 18(2):267-73, 2005. e-Pub 2005. PMID: 15492761.
Guo M, Hu L, Baliga M, He Z, Hughson MD. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 122(6):894-901, 2004. e-Pub 2004. PMID: 15539381.
He Z, Liu S, Guo M, Mao J, Hughson MD. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation. Cancer Genet Cytogenet 152(2):89-94, 2004. e-Pub 2004. PMID: 15262424.
Guo M, Lemos LB, Bigler S, Baliga M. Duodenal somatostatinoma of the ampulla of vater diagnosed by endoscopic fine needle aspiration biopsy: a case report. Acta Cytol 45(4):622-6, 2001. e-Pub 2001. PMID: 11480730.
Zhang F, Sones WD, Guo M, Xu XZ, Buncke HJ, Dorsett-Martin W, Lineaweaver WC. Reconstruction of ureteral defects with microvascular vein grafts in a rat model. J Reconstr Microsurg 17(3):179-83, 2001. e-Pub 2001. PMID: 11336149.
Lemos LB, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 5(1):1-9, 2001. e-Pub 2001. PMID: 11172200.
Zhang F, Fischer K, Komorowska-Timek E, Guo M, Cui D, Dorsett-Martin W, Buncke HJ, Lineaweaver WC. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann Plast Surg 46(3):314-9, 2001. e-Pub 2001. PMID: 11293526.
Guo M, Lemos L, Baliga M. Nodular sarcoid myositis of skeletal muscle diagnosed by fine needle aspiration biopsy. A case report. Acta Cytol 43(6):1171-6, 1999. e-Pub 1999. PMID: 10579000.
Patel MS, Thigpen JT, Vance RB, Elkins SL, Guo M. Basal cell carcinoma with lung metastasis diagnosed by fine-needle aspiration biopsy. South Med J 92(3):321-4, 1999. e-Pub 1999. PMID: 10094276.
Guo M, Lemos LB, Baliga M, Fowler JE Jr. Fine needle aspiration biopsy of the penis: transitional cell carcinoma of the urinary bladder with mucinous differentiation. Urology 51(6):1040-2, 1998. e-Pub 1998. PMID: 9609650.
Guo M, Dow KE, Kisilevsky R, Riopelle RJ. Novel neurite growth-inhibitory properties of an astrocyte proteoglycan. J Chem Neuroanat 6(4):239-45, 1993. e-Pub 1993. PMID: 8397923.
Dow KE, Guo M, Kisilevsky R, Riopelle RJ. Regenerative neurite growth modulation associated with astrocyte proteoglycans. Brain Res Bull 30(3-4):461-7, 1993. e-Pub 1993. PMID: 8457895.
Guo M, Kim LT, Akiyama SK, Gralnick HR, Yamada KM, Grinnell F. Altered expression of integrin receptors during keratinocyte activation. Exp Cell Res 195(2):315-22, 1991. e-Pub 1991. PMID: 2070815.
Guo M, Toda K, Grinnell F. Activation of human keratinocyte migration on type I collagen and fibronectin. J Cell Sci 96 ( Pt 2):197-205, 1990. e-Pub 1990. PMID: 2145292.
Guo M, Grinnell F. Basement membrane and human epidermal differentiation in vitro. J Invest Dermatol 93(3):372-8, 1989. e-Pub 1989. PMID: 2475548.
Guo M. Morphologic study on proteoglycans by cultivated fetal aortic smooth muscle cells. Zhonghua Xin Xue Guan Bing Za Zhi 16(4):239-41. e-Pub 1988. PMID: 3229338.
Fischer K, Zhang F, Komorowska-Timek E, Guo M, Dorsett-Martin W, Buncke H, Lineaweaver W. Vascular Endothelial Growth Factor Improves the Flap Survival in a Rat TRAM Flap Model. Plastic Surgical Forum 23(21).

Invited Articles

Guo M, Khanna A, Dawlett M, Patel S, Gong Y, Staerkel G. Efficacy of reflex HPV16/18 genotyping in predicting CIN3/VAIN3 in women with HPV+/Pap- results. J Am Soc Cytopathol 5(1):31-36, 2016. e-Pub 2016. PMID: 31042536.
Guo M, Khanna A, Feng J, Patel S, Zhang W, Gong Y, Huo L, Staerkel G. Analytical performance of cervista HPV 16/18 in SurePath pap specimens. Diagn Cytopathol 43(4):301-6, 2015. e-Pub 2015. PMID: 25352375.
Guo M, Khanna A, Dhillon J, Patel SJ, Feng J, Williams MD, Bell DM, Gong Y, Katz RL, Sturgis EM, Staerkel GA. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma. Cancer Cytopathol 122(2):96-103, 2014. e-Pub 2014. PMID: 24339259.
Guo M, Gong Y, Wang J, Dawlett M, Patel S, Liu P, Bevers TB, Sneige N. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results. Cancer Cytopathol 121(2):79-85, 2013. e-Pub 2013. PMID: 23225501.
Billah S, Stewart J, Staerkel G, Chen S, Gong Y, Guo M. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol 119(2):111-7, 2011. e-Pub 2011. PMID: 21400670.

Review Articles

Wen J, Fu JH, Zhang W, Guo M. Lung carcinoma signaling pathways activated by smoking. Chin J Cancer 30(8):551-8, 2011. e-Pub 2011. PMID: 21801603.
Wen J, Fu J, Zhang W, Guo M. Genetic and epigenetic changes in lung carcinoma and their clinical implications. Mod Pathol 24(7):932-43, 2011. e-Pub 2011. PMID: 21423157.
Lemos LB, Baliga M, Guo M. Blastomycosis: The great pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol 6(3):194-203, 2002. e-Pub 2002. PMID: 12089732.
Lemos LB, Guo M, Baliga M. Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol 4(6):391-406, 2000. e-Pub 2000. PMID: 11149972.

Professional Educational Materials

Guo M. The Clinical Utilization of HPV DNA Testing. Chinese Pathology Network - IPathology.
Guo M. Diagnosis and Pitfalls. Chinese Pathology Network-IPathology.
Guo M. HPV Testing in Cervical Cancer Prevention. Chinese Pathology Online School, Network-IPathology.

Editorials

Guo M. Commentary: Cervista HPV assays for FNA specimens are a valid option for HPV testing in patients with oropharyngeal carcinoma. MDLinx.
Guo M, Zhang DH, Zhang QY, Zhou L, Huo LJ, Zhang Y, Shen ZY, Zhu L. Commentary: Comparison of prevalence, viral load, physical status and expression of human papilomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer 10:650-58.

Abstracts

Shen Y, Sneige N, M|| |. A Correlation Study of Renal Pelvic Washing Cytology in Patients with Corresponding Renal Pelvic Surgical Diagnosis: Analysis on Diagnostic Discrepancy in Cytology Specimens, 2023. e-Pub 2023.
Davaro E, Tennirillo AA, Bassett R, Schmeler KM, Milbourne A, Bevers TB, Stewart J, Guo M. The Efficacy of Cobas HPV Testing to Predict CIN 2+ Lesions in Cancer Prevention Center and Gynecology Oncology Clinic : A Single Institution Experience. The 21st International Congress of Cytology presented jointly with ASC's 70th Annual Scientific Meeting, Baltimore, MD, November 15-20, 2022, 2022. e-Pub 2022.
Batmon S, Messick C, Milbourne A, Guo M, Munsell M, Fokum JD, Salcedo M, Deshmukh A, Dahlstrom K, Ogburn M, Sigel K Sturgis E, Chiao E, Schmeler KA. A prospective study of the prevalence of anal dysplasia among women with high-grade cervical , vaginal and vulvar dysplasia or cancer. SGO 2022 Annual Meeting on Women's Cancer (platform oral presentation), Phoenix, AZ, March 18-21. 2022, 2022. e-Pub 2022.
Aramin H, Chen HQ, Tinnirello AA, Sturgis E, Stewart J, Guo M. Predictive value of Cobas HPV testing for oropharyngeal squamous cell carcinoma in FNA specimens from patients with head and neck squamous cell carcinoma. 68th Annual Scientific Meeting (ASC), Las Vegas, NV, November 11-14, 2021, 2021. e-Pub 2021.
Morris VK, Jazaeri A, Westin S, Pettaway C, George S, Huey R, m O, Tu SN, Wang J, a S, Johnson B, Xiao L, Vining D, Guo M, Yuan Y, Frumovitz M. Phase I/II trial of encorafenib cetuximab and nivolumab in microsatellite stable, BRAFV600E metastatic colorectal cancer. 2021 ASCO Meeting, Chicago, IL June 4-8, 2021, 2021. e-Pub 2021.
Roy S, Khanna A, Guo M. Cumulitive risk of HSIL during a long-term follow-up for women with Pap-/HPV+ baseline testing results in a cervical cancer screening population and a cancer surveillance population. 109th United States and Canadian Academy of Pathology Annual Meeting (USCAP), Los Angeles, CA, February 25 - March5, 2020, 2020. e-Pub 2020.
Guo M, Alouch N, Sneige N. Predictive value of the Paris System for reporting urinary cytology for high-grade urothelial carcinoma in renal pelvic washing specimens. 68th Annual Scientific Meeting (ASC), Orlando, FL (Virtual), November 5-8, 2020, 2020. e-Pub 2020.
Chahoud J, Pham R, Guo M, Pickering CR, Qiao W, Khanna A, Netto F, Pettaway CA, Rao P. p16INK4a expression and survival outcomes in patients with penile squamous cell carcinoma. ASCO, Chicago, IL, May 31 - June 4, 2019, 2019. e-Pub 2019.
Anderson KS, Dahlstrom KR, Hopper M, Gillenwater AM, Kwon M, Messick C, Pettaway CA, Guo M, Sturgis EM. The hpv-related oropharyngeal and uncommon cancers screening trial of men (Houston study): a prospective screening trial for HPV oropharyngeal cancer. EUROGIN 2019, Monte Carlo, December 4-8, 2019, 2019. e-Pub 2019.
Guo, M, Khanna A, Hwang J, Xu L, Dahlstrom KR, Sturgis EM. Comparison of two commercial HPV testing assays for detection of high-risk HPV in head and neck fine-needle aspiration biopsy specimens. EUROGIN 2019, Monte Carlo, December 4-8, 2019, 2019. e-Pub 2019.
Guo, M, Khanna M, Fokum Domque J, Hwang J, Milbourne A, Sturgis EM, Messick C, Schmeler KM. Comparison of Cobas HPV with Cervista HPV Testing Assays to Detect High-risk HPV in Anal Pap Cytology Specimens. 67th Annual Scientific Meeting (ASC), Salt Lake City, UT, NOvember 14-17, 2019, 2019. e-Pub 2019.
Shlyakhova N, Khanna A, Stewart J, Guo M. Comparison of Cobas 4800 HPV and Cervista HPV HR Assays for Detecting High-risk HPV in SurePath Pap Specimens. 108th United States and Canadian Academy of Pathology Annual Meeting (USCAP), National Harbor, MD, March 16-21, 2019, 2019. e-Pub 2019.
Mousavi S, Kund U, Guo M. The Efficiency of HPV16/18Genotyping in Women with Pap-/HPV+ Co-testing Results in a Cervical Cancer Screening Population and a Cancer Surveillance Population. 107th & United States & Canadian Academy of Pathology Annual Meeting (USCAP), National Arbor, MD, March 16-21, 2019, 2019. e-Pub 2019.
Salazar K, Dawlett M, Sneige N, Gong Y, Staerkel G, Guo M. Performance of Hybrid Capture 2 and Cervista HR HPV Testing Assays for Women with Atypical Squamous Cell of Undetermined Significance Pap Test Results in Cervical Cancer Screening vs. Surveillance Population. 66th AnnualScientific Meeting (ASC), Washington DC, November 10-13, 2018, 2018. e-Pub 2018.
m G, Khanna A, Domgue JF, Hwang J, Milbourne A, Sturgis E, Messick C, Schmeler K. Validation of a Commercial HPV Testing Assay to Detect HPV16 in Anal Cytology Specimens from a High-Risk Patient Population. EUROGIN 2018 in Libson, Portugal, December 1-5, 2018, 2018. e-Pub 2018.
Domgue JF, Messick C, Milbourne A, Guo M, Salcedo M, Chiao E, Dahlstrom K, Sturgis E, Schmeler K. Prevalence of anal dysplasia and cancer in women with lower genital tract dysplasia and cancer: Preliminary results of the PANDA Study. 17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2018). Kyoto, Japan, September 14-16, 2018, 2018. e-Pub 2018.
Glisson, B, Guo, M. ISA101 and Nivolumab for incurableHPV16+ cancer: Updated results and biomarker analysis. 2018 ASCO Annual Meeting, June 1-5, 2018, 2018. e-Pub 2018.
Chen L, Jin H, Gong Y, Stewart J, Staerkel G, Guo M. Diagnostic Efficacy of Combined Fine Needle Aspiration and Core Needle Biopsy in Patients with Lung Nodules. Platform presentation at the 107th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), Vancouver, BC, Canada, 2018, 2018. e-Pub 2018.
Guo M, Khanna A, Dawlett M, Bassett R, Zhou H, Sneige N, Gong Y, Staerkel G. Population-based HPV Testing Performance: Comparison HC2 and Cervista HPV Testing Assays. Poster Presentation at EUROGIN 2017 in Amsterdam, Netherlands - October 08-11, 2017, 2017. e-Pub 2017.
Alouch N, Gong Y, Guo M. Diagnostic Accuracy and Efficacy of Renal Pelvic Washing: Clinical and Pathologic Correlation. Abstract Presentation: 65th Annual Scientific Meeting (ASC), Phoenix, AZ November 10-13, 2017, 2017. e-Pub 2017.
Glisson B, Massarelli E, William W, Johnson F, Kies M, Ferrarotto R, Guo M, Peng A, Lee J, Tran H, Young K, Haymaker C, Bernatchez C, Curran M, Espiriidion BS, Canales R, J, Wistuba I, van der Burg S, Wang J, Melief. Nivolumab and ISA 101 HPV vaccine for incurable HPV-16+ cancer. Abstract Presentation: AACR 2017 Annual Meeting, Washington, DC April 1-5, 2017, 2017. e-Pub 2017.
He J, Jerz J, Zhao J, Guo M, Gong Y. Potential factors that could lead to false positive FNA diagnosis. 65th Annual Scientific Meeting (ASC) Abstract Presentation, Phoenix, AZ November 10-13, 2017, 2017. e-Pub 2017.
Glisson B, Massarelli E, William W, Johnson F, Kies M, Ferrarotto R, Guo M, Peng A, Lee J, Tran H, Young K, Haymaker C, Bernatchez C, Curran M, Espiriidion BS, Canales R, J, Wistuba I, van der Burg S, Wang J, Melief. Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer. Abstract Presentation: ESMO 2017 Congress, Madrid, Spain September 8-12, 2017, 2017. e-Pub 2017.
Guo M, Ariza-Heredia E, Ying J. Time to Re-evaluate Recommendations for Prevention of Human Papillomavirus (HPV) Infections after Stem Cell Transplantation (HSCT). 27th ECCMID Congress, Vienna, Austria April 22-25, 2017, 2017. e-Pub 2017.
Zhou H, Bassett R, Khanna A, Dawlett M, Sneige N, Schmeler K, Milbourne A, Bevers T, Gong Y, Staerkel G, Guo M. Population-based HPV Testing Performance: Potential False Negative HPV Results in a Cervical Cancer Surveillance Population. Poster Presentation at EUROGIN 2016 in Salzburg, Austria, 2016. e-Pub 2016.
Chen YJ, Guo M. Accuracy of the EasyChip HPV Blot Genotyping Assay in Detecting High-Risk HPV Genotypes in SurePath Pap Specimens. Poster Presentation at the 47th SGO Annual Meeting on Women's Cancer, San Diego, CA, 2016. e-Pub 2016.
Crumley SM, Zhou H, Lyons G, Bassett RL, Khanna A, Staerkel G, Guo M. False Negative HPV Tests in Women with High Grade Squamous Intraepithelial Lesion or Carcinoma Pap Tests: Clinical-Pathological Correlation. 105th United States & Canadian Academy of Pathology Annual Meeting (USCAP), Seattle, WA, 2016. e-Pub 2016.
Ruiz-Cordero R, Khanna A, Robinson M, Lyons GR, Bassett RL, Stewart J, Gong Y, Staerkel G, Guo M. Flourescence in-situ Hybridization Testing in Cytology Specimens of Patients with Lung Carcinoma. 64th Annual Scientific Meeting (ASC) Poster Presentation, New Orleans, 2016. e-Pub 2016.
Leng B, Guo M, Gong Y. Utility and Pitfalls of GATA3 Immunocytochemistry for Diagnosis of Breast and Urothelial Carcinomas in Cytology Specimens. 105th United States & Canadian Academy of Pathology Annual Meeting (USCAP), Seattle, WA, 2016. e-Pub 2016.
Roy Chowdhuri S, Luthra R, Guo M, Khanna A, Lyons GR, Bassett RL, Heymach J, Patel KP. Correlation of FISH and NGS Results of Lung Adenocarcinoma Cytology Samples Stratified by Molecular Subtytpes. Association for Molecular Pathology (AMP) Annual Meeting Poster Presentation, Charlotte, NC, 2016. e-Pub 2016.
Davis D, Khanna A, Dawlett M, Guo M. Efficacy of HPV Testing in Predicting CIN2+ in Women with an Unsatisfactory Pap Cytology Result. American Society of Cytopathology,Poster Presentation at 63rd Annual Scientific Meeting ASC ,Chicago, IL 4(6):54, 2015. e-Pub 2015.
Khanna A, Tasto A, Feng J, Cortes A, Guo M, Krishnamurthy S. The Utility of Cervista Human Papillomavirus Assay in Necrotic Fine-needle Aspiration Specimens of Metastatic Squamous Cell Carcinoma from Neck Lymph Nodes. American Society of Cytopathology, Poster Presentation at 63rd Annual Scientific Meeting ASC ,Chicago 4(6):83, 2015. e-Pub 2015.
Zhou H, Khanna A, Sneige N, Staerkel G, Guo M. Clinical Performance of Cervista HPV HR and HC2 Co-testing with SurePath Pap Cytology. American Society of Cytopathology, Poster Presentation at 63rd Annual Scientific Meeting ASC, Chicago, IL 4(6):PP05, 2015. e-Pub 2015.
Guo M, Zhou H, Khanna A, Sneige N, Staerkel G. HPV-Negative Pap Specimens with High-Grade Cervical Intraepithelial Lesion or Cervical Carcinoma:Potential to be Missed by HPV Testing as Primary Cervical Cancer Screening. 19th International Meeting of the European Society of Gynaecological Oncology 2015 (ESGO), Nice, France, 2015. e-Pub 2015.
Guo M, Khanna A, Patel S, Williams M, Sturgis E, Gong Y, Staerkel G. Cervista HPV 16/18 and HPV HR Assays can be used in Tissue Specimens of Oropharyngeal Squamous Carcinoma Patients to Determine High-Risk HPV Status. 9th Asia Pacific IAP Congress 2015, Brisbane, Australia, 2015. e-Pub 2015.
Nelles N, Khanna A, Patel S, Gong Y, Guo M. Predictive Value of HPV testing for high-grade cervical and vaginal intraepithelial lesions in patients with mildly abnormal Pap testing results and therapy effects. Poster presentation at the 104th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2015. e-Pub 2015.
Khanna A, Patel S, Gong Y, Sneige N, Staerkel G, Guo M. The Efficacy of HPV16/18 Genotyping in Predicting CIN2+ in Women with HPV+/Pap Results. Journal of the American Society of Cytopathology 3(5):PP03, 2014. e-Pub 2014.
Khanna A, Dawlett M, Kologinczak T, Wang J, Patel S, Bevers T, Sneige N, Guo M. Can HPV Testing be Used as a First-line Screening Test for Cervical Cancer Prevention? Three Year Cummulative Risk of CIN2+ in Women Aged 30 Years and Older Screened by Pap and HPV Co-testing. Journal of the American Society of Cytopathology 3(5):S67, 2014. e-Pub 2014.
Zhang YH, Liu J, Dawlett M, Guo M, Sun X, Gong Y. The Role of SoX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Poster Presentation at the 103rd Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 27(250), 2014. e-Pub 2014.
Khanna A, Dawlett M, Patel S, Sneige N, Staerkel G, Guo M. Efficacy of Reflex HPV Testing in older, High-Risk Patients with an ASC-US Pap Results. Journal of the American Society of Cytopathology 2(1s):S39, 2013. e-Pub 2013.
Zhang H, Feng J, Sneige N, Lai H, Guo M. Aberrant DNA Methylation of SOX1 and PAX1 in Pap Specimen: Potential Biomarkers of Cervical Intraepithelial Neoplasm Grade 3. 61st Annual S Journal of the American Society of Cytopathology 2(1s):S65, 2013. e-Pub 2013.
Zhang H, Khanna A, Feng J, Patel S, Staerkel G, Guo M. Validation of Cervista HPV16/18 Assay in Anal Swab Specimens. Modern Pathology 26(s2):109A, 2013. e-Pub 2013.
Stewart J, Guo M. Fine Needle Aspiration Is a Valid Tissue Source for EGFR and KRAS Molecular Testing in Lung Cancer: A Comparison Study with Core Needle Biopsy. Modern Pathology 26(s2):103A, 2013. e-Pub 2013.
Wang J, Guo M, Gong Y. Fine Needle Aspiration of Lymphoma with Signet Ring Features. Journal of the American Society of Cytopathology 1(1):S92, 2012. e-Pub 2012.
Dawlett M, Kologinczak T, Wang JP, Sneige N, Bevers T, Guo M. Three-Year Follow-up for Women 30 Years and Older with Negative Pap and Negative Hybrid Capture 2 HPV DNA Testing Results. Journal of the American Society of Cytopathology 1(1):S40, 2012. e-Pub 2012.
Guo M, Dhillon J, Khanna A, Katz R, Gong Y, Staerkel G. Cervista HPV HR and HPV16/18 Assays in Head and Neck FNA Specimens, a Valid Option of HPV Testing, Compared with HPV In Situ Hybridization/p16 Immunostaining Assays in Tissue Specimens from Patients with Oropharyngeal Carcinoma. Journal of the American Society of Cytopathology 1(1):S71, 2012. e-Pub 2012.
Wang JP, Kologinczak T, Dawlett M, Bevers T, Sneige N, Guo M. Risk of CIN2+ in Women 30 Years and Older with Negative Pap and Positive Hybrid Capture 2 HPV DNA Testing Results. Journal of the American Society of Cytopathology 1(1):S52, 2012. e-Pub 2012.
Khanna A, Patel S, Feng J, Staerkel G, Guo M. Validation of Cervista HPV HR and Cervista HPV 16/18 Assays in Head and Neck FNA Specimens from Patients with Oropharyngeal Carcinoma. Journal of the American Society of Cytopathology 1(1):S71, 2012. e-Pub 2012.
Khanna A, Patel S, Payne L, Staerkel G, Guo M. Validation of Cervista HPV HR DNA Testing Assay in SurePath Pap Specimens. Journal of the American Society of Cytopathology 1(1):S36, 2012. e-Pub 2012.
Si Q, Landon G, Guo M, Staerkel G, Caraway N. Endoscopic Ultrasound-Guided Fine Needle Aspiration of Metastatic Non-Hematolymphoid Neoplasms to the Pancreas. Journal of the American Society of Cytopathology 1(1S):S99, 2012. e-Pub 2012.
Guo M, Huang M, Ge Y, Hess K, Wei C, Zhang W. Stage-associated difference in microrna expression in lung adenocarcinoma from smokers and non-smokers. Annals of Oncology, 2012. e-Pub 2012.
Khanna A, Patel S, Payne L, Staerkel G, Guo M. Validation of Cervista HPV16/18 in SurePath Pap Specimens Using a PCR-based HPV Genotyping Assay. Modern Pathology 25(2):94A (Abstract #386), 2012. e-Pub 2012.
Guo M. Risk Profiling Using HPV Genotyping in Women with Midly Abnormal Pap Results (Platform Presentation). 59th Annual Scientific Meeting of the American Society of Cytopathology, 2011. e-Pub 2011.
Landon G, Si Q, Guo M, Sneige N, Gong Y. Atypical epithelial cells in fine-needle aspiration biopsy of breast lesions: histologic follow-up and sources of equivocal cytologic diagnosis. 59th Annual Scientific Meeting of the American Society of Cytopathology, Baltimore, MD, 2011. e-Pub 2011.
Guo M, Si QS, Gong Y, Kalhor N, Chen S, Moran C. EGFR mutations in exons 19 and 21 are closely associated with TTF-1 positive lung adenocarcinoma. 100th Annual Meeting, The United States and Canada Academy of Pathology, San Antonio, TX 24(Suppl 1):411A (#1749), 2011. e-Pub 2011.
Li Z, Austin RM, Guo M, Zhao C. Pap Cytology and Hybrid Capture 2 (HC2) HPV DNA Testing in 234 Patients with Cervical Squamous Carcinoma. 100th Annual Meeting, The United States and Canada Academy of Pathology, San Antonio, TX 24(Suppl 1):255A (#1082), 2011. e-Pub 2011.
Guo M, Huang M, Li M, Cogdell D, Caling G, Hess K, Zhang W. Altered MicroRNA Expression in Adenocarcinoma of Lung from Smokers and Never-Smokers. 100th Annual Meeting, The United States and Canada Academy of Pathology, San Antonio, TX 24(Suppl 1):443A (#1884), 2011. e-Pub 2011.
Diaz A, Dawlett M, Wang JP, Jack A, Guo M. Predictive Value of Reflex HPV DNA Testing in Post-treatment Follow up for Women with ASC-US Pap Results. 58th Annual Scientific Meeting of the American Society of Cytopathology, Boston, MA 118(Suppl 5):335 (#32), 2010. e-Pub 2010.
Chen S, Si QS, Guo M. Malignant Pleural Effusion in Pediatric and Adolescent Patients, Our Experience in a Cancer Center. 58th Annual Scientific Meeting of the American Society of Cytopathology, Boston, MA 118(Suppl 5):320 (#10), 2010. e-Pub 2010.
Guo M, Sneige N, Patel S, Feng J, Papadimitrakopoulou V, Stugis E, Etzel C, Hong WK, Tsao A. HPV Infection and Oral Cytological Changes in Patients with Oropharyngeal Squamous Carcinoma and Their Sexual Partners. 58th Annual Scientific Meeting of the American Society of Cytopathology, Boston, MA 118(Suppl 5):349 (#52), 2010. e-Pub 2010.
Papadimitrakopoulou V, Guo M, Etzel C, Solomon B, Sturgis EM, Lippman SM, Hong WK, Tsao AS. Human Papillomavirus (HPV) Transmission from Oropharyngeal Cancer Patients to Sexual Partners. 2010 American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2010. e-Pub 2010.
Billah S, Guo M. The Utility of Cytologic Specimens for Molecular Testing, Our Experience in a Cancer Center. 99th Annual Meeting, The United States and Canada Academy of Pathology, Washington D.C 23(Suppl 1):88A (#386), 2010. e-Pub 2010.
Wang JP, Jie F, Shobha P, Ming G. Comparison of Two Preservation Methods of Residual Liquid-Based Pap Specimens for Future Morphology and Molecular Studies. The 57th Annual Scientific Meeting of the American Society of Cytopathology, Denver, CO 117(Suppl 5):391 (#56), 2009. e-Pub 2009.
Long SL, Kott, M, Guo M, Piao Y. Touch Prep Technique in Adequacy Evaluation of Ultrasound-Guided or CT-Guided Needle Core Biopsy of Hepatic Lesions. The 57th Annual Scientific Meeting of the American Society of Cytopathology, Denver, CO 117(Suppl 5):412 (#92), 2009. e-Pub 2009.
Dawlett M, Wang JP, Patel S, Gong Y, Bevers T, Sneige N, Guo M. Co-screening Women 30 Years of Age and Older Using Hybrid Capture 2 HPV DNA Testing and Pap Cytology: 2-year Experience in a Cancer Prevention Center (Platform Presentation). The 57th Annual Scientific Meeting of the American Society of Cytopathology, Denver, CO 117(Suppl 5):356 (PP#13), 2009. e-Pub 2009.
Kurian Elizabeth M, Marilyn D, Jianping W, Ming G. Diagnostic Accuracy of Fine Needle Aspiration Biopsy for Follicular Variant of Papillary Thyroid Carcinoma. The 57th Annual Scientific Meeting of the American Society of Cytopathology, Denver CO 117(Suppl 5):428 (#119), 2009. e-Pub 2009.
Guo M. HPV DNA testing in Cervical Cancer Prevention: Practical Aspects and Clinical validation. Journal of the Japanese Society of Clinical Cytology, 50th Annual Meeting, Tokyo, Japan:155-156, 2009. e-Pub 2009.
Guo M, Baruch A, Deavers M, Jan YJ, Silva E, Lin E, Sneige N. Testing Efficacies of p16, ProExC and HPV In-Situ Hybridization in Cervical Squamous Intraepithelial Lesions and Carcinoma. The United States and Canada Academy of Pathology, 98th Annual Meeting, Boston, MA 22(Suppl 1):216A (#983), 2009. e-Pub 2009.
Wang JP, Dawlett M, Guo M. FNA Biopsy of Thyroid Bed Lesions from 208 Patients with Thyroidectomy for Thyroid Carcinoma, 5 Years Experience in a Cancer Center. The 56th Annual Scientific Meeting of the American Society of Cytopathology, Orlando, FL 114(Suppl 5):441 (#145), 2008. e-Pub 2008.
Zenali M, Kott M, Tan P, Guo M, Paio YC. The Role of Reflex High-Risk HPV DNA Test in the Triage of Women with ASC-H. The 56th Annual Scientific Meeting of the American Society of Cytopathology, Orlando, FL 114(Suppl 5):372 (#36), 2008. e-Pub 2008.
Guo M, Lin CY, Lai HC, Cogdell DE, Zhang W, Lin E, Sneige N. Genotyping for Eight Oncogenic Types of Human Papillomavirus Can Improve Specificity of HPV Testing in Women with Mild Abnormal Pap Results (Platform Presentation). The Annual World Cancer Congress, Shanghai, China:1037-1043, 2008. e-Pub 2008.
Warraich I, Mutyama B, Patel S, Cogdell D, Zhang W, Lin E, Gong Y, Sneige N, Guo M. HPV DNA testing with selected HPV genotyping is more efficient than p16 immunostaining in predicting high-grade cervical intraepithelial neoplasia in women with atypical squamous cells of undetermined significance (ASC-US) (Platform Presentation). The 55th Annual Scientific Meeting of the American Society of Cytopathology, Houston, TX 111(Suppl 5):348 (#PF5), 2007. e-Pub 2007.
Guo M, Lin CY, Lai HC, Cogdell DE, Zhang W, Lin E, Sneige N. Genotyping for Eight Oncogenic Types of Human Papillomavirus Can Improve Specificity of HPV Testing in Women with Mild Abnormal Pap Results. The 60th Annual Symposium on Cancer Research, Personalized Risk Assessment and Management Houston, TX, 2007. e-Pub 2007.
Guo M, Lin CY, Lai HC, Cogdell DE, Zhang W, Lin E, Sneige N. Genotyping for Eight Oncogenic Types of Human Papillomavirus Can Improve Specificity of HPV Testing in Women with Mild Abnormal Pap Results. EUROGIN, Monte-Carlo, Monaco, 2007. e-Pub 2007.
Guo M, Gong Y, Dawlett M, Patel S, Bevers T, Sneige N. HPV DNA Co-screening with Pap Cytology in Women Age 30 and Older in a Cancer Prevention Center. The 55th Annual Scientific Meeting of the American Society of Cytopathology, Houston, TX 111(Suppl 5):386 (#53), 2007. e-Pub 2007.
Siddiqi A, Spataro A, Balliga M, Lin E, Guo M. Comparison of ThinPrep and SurePath Liquid-based Cytology in Using Hybrid Capture 2 HPV DNA Testing in Women with ASC-US Pap results. The 55th Annual Scientific Meeting of the American Society of Cytopathology, Houston, TX 111(Suppl 5):359 (#8), 2007. e-Pub 2007.
Guo M, Sneige N, Gong Y, Deavers M, Silva E, Jan YJ, Zhang W, Cogdell D, Lin E, Luthra R. Comparison of INFORM HPV in Situ Hybridization with PCR Assay for Detection of Human Papillomavirus (HPV) in Cervical Carcinoma and Cervical Intraepithelial Neoplasia. Pathology of the 21st Century, Integrating Diagnostic and Molecular Pathology, Houston, TX, 2007. e-Pub 2007.
Guo M, Sneige N, Silva E, Jan YJ, Cogdell D, Lin E, Luthra R, Zhang W. Distribution and Viral Load of Eight Oncogenic Types of Human Papillomavirus (HPV) and HPV 16 Integration Status in Cervical Intraepithelial Neoplasia and Carcinoma. Pathology of the 21st Century, Integrating Diagnostic and Molecular Pathology, Houston, TX, 2007. e-Pub 2007.
Guo M, Sneige N, Zhang W, Silva E, Cogdell D, Jan YJ, Lin E, Luthra R. Distribution and Viral Load of Eight Oncogenic Types of Human Papillomavirus (HPV) and HPV 16 Integration Status in Cervical Intraepithelial Neoplasia and Carcinoma. The United States and Canada Academy of Pathology, 96th Annual Meeting, San Diego, CA 20(Suppl 2):199A (#908), 2007. e-Pub 2007.
Guo M, Sneige N, Gong Y, Deavers M, Silva E, Jan YJ, Zhang W, Cogdell D, Lin E, Luthra R. Comparison of INFORM HPV in Situ Hybridization with PCR Assay for Detection of Human Papillomavirus (HPV) in Cervical Carcinoma and Cervical Intraepithelial Neoplasia. The United States and Canada Academy of Pathology, 96th Annual Meeting, San Diego, CA 20(Suppl 2):199A (#909), 2007. e-Pub 2007.
Ge Y, Sneige N, Eltorky MA, Gong Y, Guo M. Immunohistochemical Characterization of Subtypes of Male Breast Carcinoma. The University of Texas MD Anderson Cancer Center 10th Annual Trainee Recognition Day and Research Symposium, Houston, TX, 2006. e-Pub 2006.
Ge Y, Sneige N, Eltorky MA, Gong Y, Guo M. Immunohistochemical Characterization of Subtypes of Male Breast Carcinoma. The United States and Canada Academy of Pathology, 95th Annual Meeting, Atlanta, GA 19(Suppl 1):27A (#115), 2006. e-Pub 2006.
Guo M, Sneige N, Jan YJ, Mutyala B, Patel S, Dunmire V, Cogdell D. p16 Immunostain in Conjunction with Cytomorphology for Triage of Women with ASC-US: A Comparison Study with HPV DNA Testing. The 53rd Annual Scientific Meeting of the American Society of Cytopathology, San Diego, CA 105(Suppl5):375 (#95), 2005. e-Pub 2005.
Guo M, Jan YJ, Gong Y, Jacob B, Sneige N. Clinical Utility of Immunostains in the Differential Diagnosis of Lung Malignancies by FNA Biopsies. The 53rd Annual Scientific Meeting of the American Society of Cytopathology, San Diego, CA 105(Suppl 5):404 (#152), 2005. e-Pub 2005.
Guo M, Sneige N, Jan YJ, Cogdell D, Dunmire V. Does HPV Genotyping Help to Predict the Presence of CIN 2/3 in Women with Mild Abnormal Pap Results?. The 53rd Annual Scientific Meeting of the American Society of Cytopathology, San Diego, CA 105(Suppl 5):376 (#97), 2005. e-Pub 2005.
Shi K, Wang W, Guo M, Amra S, McLaughlin W, et al. Early Detection of Brain and Bone Metastases using Kodak Multimodal Imaging System. The 4th Annual Meeting of the Society for Molecular Imaging, Cologne, Germany, 2005. e-Pub 2005.
Shi K, Houston J, Wang W, Guo M, Amra S, Charnsangavej C, et al. Real time near-infrared optical imaging guided brain tumor surgery in animal model. The 4th Annual Meeting of the Society for Molecular Imaging, Cologne, Germany, 2005. e-Pub 2005.
Guo M, Hu L, Jan YJ, He Z, Baliga M. Efficacy of p16INK4a as a triage tool for women with LSIL Pap Results. The 4th Annual Meeting of Asia-Pacific International Academy of Pathology, Beijing China, 2005. e-Pub 2005.
Guo M, Hu L, Zhou J, He Z, Martin L, Baliga M. Predictive Value of p16INK4a in Detection of CIN 2/3 from Women with LSIL Pap Results, a Biopsy Comparison Study. United States and Canadian Academy of Pathology Annual Meeting, San Antonio, TX, 2005. e-Pub 2005.
Guo M, Hu L, Baliga M, Martin L, Liu S, He Z. Predictive Value of p16INK4a in Detection of CIN 2/3 from High-risk HPV Positive ASC-US: A Biopsy Comparison Study. The 52nd Annual Scientific Meeting of the American Society of Cytopathology, Chicago, IL, 2004. e-Pub 2004.
Hu L, Guo M, Ho Z, Liu S, May W, Hughson M. p16 INK4a expression and human papillomavirus types 16/18 infection in cervical intraepithelial neoplasm of adolescents. United States and Canadian Academy of Pathology Annual Meeting, Vancouver, BC, Canada, 2004. e-Pub 2004.
Sagun ED, Guo M, Hu L, Martin L, Alexander R, Baliga M. ASCUS Diagnoses by ThinPrep and Conventional Pap Tests: A Biopsy Follow-up Study. American Society of Cytopathology 51st Annual Scientific Meeting, Orlando, FL, 2003. e-Pub 2003.
Guo M, Hu L, Baliga M, Martin L, Liu S, Coleman J, Wilkins K, Hughson M. A Better Predictive Value of p16INK4a Than High-risk HPV Testing for High-grade Cervical Intraepithelial Neoplasm. American Society of Cytopathology 51st Annual Scientific Meeting, Orlando, FL, 2003. e-Pub 2003.
Chen GF, Song Y, Guo M. Attached explant method for cell culture of human aortic smooth muscle. Zhonghua Xin Xue Guan Bing Za Zhi 14(6):361-2, 381, 1986. e-Pub 1986. PMID: 3582163.
Shitawi M, Tinnirello AA, Guo M. Concordance between cobas and RNAScope in situ hybridization testing for human papillomavirus in squamous carcinoma from patients with head and neck fine needle aspiration and surgical specimens. 114th Annual Meeting USCAP.
Dahistrom, KR, Guojun L, Guo M, Yarbrough WG, Sturgis EM. Circulating tumor HPV DNA as a marker for HV-related oropharyngeal cancer vs cancer-free controls with and without oral HPV infection. EUROGIN.
Roy S, Khanna A, Guo M. Cumulative risk of HSIL during a long-term follow-up for women with Pap-/HPV+ baseline testing results in a cervical cancer screening population and a cancer surveillance population. 109th USCAP.

Book Chapters

Guo M. Chapter 11: Human Papillomavirus (HPV) Testing on Cervical Cytology Specimens. In: Molecular Diagnostics Cytopathology. Springer.
Guo M. Section 2: Mediastinum, Part IV: Fine Needle Aspiration, Deep Organs and Tissues. In: Diagnostics Pathology, Cytopathology. Amirsys Publishing.
Guo M. Molecular Pathology of Cervical Dysplasia and Carcinoma. In: Precision Molecular of Uterine Cancer. Springer.

Less

CV information above last modified July 22, 2026

Ming Guo, M.D.

About Dr. Ming Guo

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Professional Educational Materials

Editorials

Abstracts

Book Chapters

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Ming Guo, M.D.

About Dr. Ming Guo

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Professional Educational Materials

Editorials

Abstracts

Book Chapters

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson